Chemical name: (1S)-N,N-dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amine
Formula: C21H23NO
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid

DURATIA-30

DURATIA-30, manufactured by Fortune Health Care, is a pharmaceutical solution designed to address the issue of premature ejaculation (PE) in men. Each package of DURATIA-30 contains 10 pills, with each pill containing 30mg of Dapoxetine, the active substance.

Key Features:

1. Premature Ejaculation Treatment: DURATIA-30 contains Dapoxetine, a selective serotonin reuptake inhibitor (SSRI) specifically developed for the treatment of premature ejaculation in men aged 18-64 years. Dapoxetine works by increasing serotonin levels in the brain, thereby delaying the ejaculatory reflex and prolonging the time to ejaculation.
2. Rapid Onset of Action: DURATIA-30 is known for its rapid onset of action, with effects typically seen within 1-2 hours after ingestion. This allows for on-demand treatment of premature ejaculation, providing greater flexibility and spontaneity in sexual activity.
3. Extended Duration of Action: Dapoxetine has a relatively short half-life compared to other SSRIs, allowing for rapid clearance from the body and minimizing the risk of accumulation and side effects. Despite its short duration of action, DURATIA-30 provides sufficient efficacy in delaying ejaculation to improve sexual satisfaction and performance.
4. Improved Control Over Ejaculation: By modulating serotonin levels in the brain, DURATIA-30 helps men gain better control over their ejaculatory response, leading to increased confidence and satisfaction in sexual encounters. It allows individuals to prolong intercourse and achieve more fulfilling sexual experiences.
5. Well-Tolerated: DURATIA-30 is generally well-tolerated, with most adverse effects being mild to moderate in severity. Common side effects may include nausea, headache, dizziness, and insomnia. Serious adverse effects such as serotonin syndrome or suicidal thoughts are rare but may occur in susceptible individuals.

Usage Guidelines:

• DURATIA-30 should be taken orally with a full glass of water, approximately 1-3 hours before anticipated sexual activity.
• The recommended dosage of DURATIA-30 is one tablet (30mg) per day. Dosage adjustments may be made based on individual response and tolerability.
• DURATIA-30 should not be used more than once within a 24-hour period, and it is not intended for continuous daily use.

DURATIA-30 offers men suffering from premature ejaculation a safe and effective treatment option to improve their sexual performance and satisfaction. With its rapid onset of action, extended duration of efficacy, and favorable safety profile, DURATIA-30 stands as a valuable therapeutic solution for enhancing sexual well-being and quality of life.